Ignite Creation Date:
2024-05-06 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03546894
Status:
COMPLETED
Last Update Posted:
2024-07-15
First Post:
2018-05-23
Brief Title:
A Study to Determine Progression-free Survival PFS and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive ALK Non-Small Cell Lung Cancer NSCLC Treated With Anaplastic Lymphoma Kinase ALK Inhibitors
Sponsor:
Organization:
Takeda
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
111
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 48592 |
Who Masked List: